Torsten Pietsch
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Genetics 362
- Glioma Diagnosis and Treatment 361
- Genomic variations and chromosomal abnormalities 10
-
- Chromatin Remodeling and Cancer 14
- Epigenetics and DNA Methylation 11
- Wnt/β-catenin signaling in development and cancer 10
- Co-authors
- Guido Reifenberger (35 shared papers)Andreas von Deimling (31 shared papers)Michael Weller (26 shared papers)Matthias Simon (22 shared papers)Monika Warmuth‐Metz (77 shared papers)Otmar Dieter Wiestler (26 shared papers)Andreas Waha (50 shared papers)Stefan Rutkowski (75 shared papers)
- Journals
- Neuro-Oncology (51 papers)Acta Neuropathologica (40 papers)Journal of Neuro-Oncology (31 papers)International Journal of Cancer (29 papers)Journal of Neuropathology & Experimental Neurology (16 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Torsten Pietsch
477 papers receiving 32.7k citations
Torsten Pietsch's Hit Papers
Peers
Comparison fields: 5 of 154
- Genetics 19.6k
- Cancer Research 1.7k
- Molecular Biology 6.1k
- Hepatology 719
- Developmental Neuroscience 238
Countries citing papers authored by Torsten Pietsch
This map shows the geographic impact of Torsten Pietsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Pietsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Pietsch more than expected).
Fields of papers citing papers by Torsten Pietsch
This network shows the impact of papers produced by Torsten Pietsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Pietsch. The network helps show where Torsten Pietsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Torsten Pietsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 489 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA methylation-based classification of central nervous system tumours Hit paper breakdown → | 2018 | 2219 |
| 2 | Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors Hit paper breakdown → | 2002 | 890 |
| 3 | EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME Hit paper breakdown → | 2008 | 888 |
| 4 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2014 | 883 |
| 5 | Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas Hit paper breakdown → | 2012 | 808 |
| 6 | New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Hit paper breakdown → | 2016 | 728 |
| 7 | Long-term survival with glioblastoma multiforme Hit paper breakdown → | 2007 | 722 |
| 8 | Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas Hit paper breakdown → | 2010 | 693 |
| 9 | NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide Hit paper breakdown → | 2009 | 669 |
| 10 | 2005 | 602 | |
| 11 | 2008 | 585 | |
| 12 | Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network Hit paper breakdown → | 2009 | 526 |
| 13 | Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma Hit paper breakdown → | 2014 | 520 |
| 14 | Risk stratification of childhood medulloblastoma in the molecular era: the current consensus Hit paper breakdown → | 2016 | 500 |
| 15 | 2010 | 482 | |
| 16 | 1996 | 461 | |
| 17 | 2016 | 442 | |
| 18 | 2008 | 422 | |
| 19 | cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading Hit paper breakdown → | 2020 | 394 |
| 20 | 2013 | 381 |
About Torsten Pietsch
Torsten Pietsch is a scholar working on Genetics, Molecular Biology, Hepatology, Cancer Research and Oncology, having authored 489 papers that have together received 33.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (361 papers), Chromatin Remodeling and Cancer (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pituitary Gland Disorders and Treatments (11 papers), Epigenetics and DNA Methylation (11 papers), Wnt/β-catenin signaling in development and cancer (10 papers), Genomic variations and chromosomal abnormalities (10 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Genetics (19.6k citations), Cancer Research (1.7k citations), Molecular Biology (6.1k citations), Hepatology (719 citations) and Developmental Neuroscience (238 citations). Torsten Pietsch has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Guido Reifenberger, Andreas von Deimling, Michael Weller, Matthias Simon, Monika Warmuth‐Metz, Otmar Dieter Wiestler, Andreas Waha, Stefan Rutkowski, Gabriele Schackert and Dietrich von Schweinitz. Their work appears in journals such as Neuro-Oncology, Acta Neuropathologica, Journal of Neuro-Oncology, International Journal of Cancer and Journal of Neuropathology & Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.